H1N1 vaccine maker GlaxoSmithKline has recalled a batch of the vaccine after several "unusually" severe reactions in several Canadians. Meanwhile, several cases of the potentially life-threatening syndrome Guillain Barre, have been reported in the U.S..
Read more »














